Charts

05 Feb, 2023

News

27 Jan, 2023
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
19 Jan, 2023
By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT LGVN (NASDAQ:LGVN) is a clinical stage biotech company that is using cutting edge cellular technology for various major medical conditions that we believe is undervalued by investors who are not appreciating the game-changing potential that the signature treatment, Lomecel-B, has to impact people’s lives. That belief was
-- Full results published in European Heart Journal Open -- -- Study met primary safety endpoint -- -- All patients alive, transplant-free, and maintained expected rate of growth one year after treatment -- -- Data supports ongoing clinical development of Lomecel-BTM for HLHS, currently being evaluated in a Phase 2a trial -- MIAMI, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines
13 Jan, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards. The post 3 Penny Stocks That Could Rise 500% in 2023 appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
06 Jan, 2023
Shares ofLongeveron(NASDAQ: LGVN) are trading 5.37% higher amid strength in Alzheimer's-related stocks after the FDA ...
– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty in Japan in 1Q23 – – Extended cash runway into 2H24 – MIAMI, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today provided a corporate update highlighting the Company’s strategic priorities and anticipated milestones for 2023. “This past year Longeveron m
– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty in Japan in 1Q23 – – Extended cash runway into 2H24 – MIAMI, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today provided a corporate update highlighting the Company’s strategic priorities and anticipated milestones for 2023. “This past year Longeveron m
19 Dec, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Elon Musk is great at timing the market. He's selling TSLA stock now, and savvy investors would be wise to follow suit. The post Elon Musk Is a Genius Market Timer. That’s Bad News for Tesla (TSLA) Stock. appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
13 Dec, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 ...
29 Nov, 2022
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that Company leadership will participate in three upcoming investor conferences. A.G.P.’s Virtual Biotech ConferenceFormat: One-on-one Meetings Date: Wednesday, November 30, 2022Location: Virtual The Benchmark Company 11th Annual Discovery One-on-One Investor ConferenceFormat: One-on-
16 Nov, 2022
Longeveron ( NASDAQ:LGVN ) Third Quarter 2022 Results Key Financial Results Net loss: US$5.24m (loss widened by 8.0...
14 Nov, 2022
-- Achieved key clinical and regulatory milestones across clinical pipeline, including the completion of enrollment in Longeveron’s Phase 2a trial for Alzheimer’s Disease -- -- Conference call scheduled for 8:30 a.m. ET today -- MIAMI, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today provided a business update and reported its financial results for
12:15
Yahoo! Finance
By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a clinical stage biotech company that is using cutting edge cellular technology to treat a rare heart disease and the impacts of aging. Longeveron reported a 3Q 2022 loss of $0.25/per share, in line with the same quarter last year and within the range of expectations. More importantly, on a conference
10 Nov, 2022
MIAMI, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced the completion of enrollment in its Phase 2a trial of Lomecel-BTM in patients with mild Alzheimer’s Disease (AD). “We are pleased to have completed enrollment in our Phase 2a study of Lomecel-BTM for Alzheimer’s Disease. We look forward to building on our Phase 1b study, which met its
07 Nov, 2022
Live conference call on Monday, November 14 at 8:30 a.m. ESTMIAMI, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that the Company will release its third quarter 2022 financial results on Monday, November 14, 2022 before the open of the U.S. financial markets. Management will host a conference call to discuss the Company’s financial resu
23 Oct, 2022
14:15
FinancialContent
10 Oct, 2022
17:31
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for 10X stocks should prioritize companies in high-growth areas that demonstrate high earnings quality. The post How to Find Stocks That Rise 10x appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
09 Oct, 2022
05 Oct, 2022
Some Longeveron Inc. ( NASDAQ:LGVN ) shareholders are probably rather concerned to see the share price fall 36% over...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. The post Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022. Longeveron’s presentation will take place on Wednesda
29 Sep, 2022
Gainers Immunovant (NASDAQ:IMVT) shares increased by 29.2% to $6.19 during Thursday's regular session. Immunovant's stock ...
28 Sep, 2022
One of the most-watched Alzheimer's therapies in the clinic,Biogen Inc(NASDAQ: BIIB)-Eisai Limited's(OTC: ...
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on ...
15 Sep, 2022
Executive brings more than 30 years of global biopharmaceutical operations and program management experienceMIAMI, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced it has named Jerome Bailey as the company’s new vice president of business operations. He joins the company from Checkmate Pharmaceuticals (acquired by Regeneron), where he served as senior director of pr
14 Sep, 2022
09 Sep, 2022
Longeveron (NASDAQ:LGVN) brought in sales totaling $466 thousand during Q2 according to data provided by Benzinga Pro. However, earnings ...
06 Sep, 2022
MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming H.C. Wainwright 24th Annual Global Investment Conference taking place in New York City from September 12-14, 2022. Longeve
31 Aug, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pfizer (PFE) and Moderna (MRNA) stocks are in the news Wednesday as the FDA approves new booster shots for the Covid-19 Omicron variant. The post PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Longeveron (LGVN) stock is on the move Wednesday after the FDA granted its fast-track designation for heart treatment Lomecel-B. The post Why Is Longeveron (LGVN) Stock on the Move Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Longeveron (NASDAQ: LGVN) received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead drug ...
New designation may expedite FDA review and potential approval to address this life-threatening heart condition affecting approximately 1,000 babies per yearMIAMI, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Lomecel-B™ for t
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation toLongeveron Inc(NASDAQ: LGVN) Lomecel-B for ...
26 Aug, 2022
Longeveron Inc. (NASDAQ: LGVN) announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a ...
25 Aug, 2022
Issued claims will protect use of a biomarker to assess response to Lomecel-B™ in patients with blood vessel dysfunctionMIAMI, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, today announced that the European Patent Office (EPO) has issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to methods to treat
The European Patent Office has issued a notice of its intent to grantLongeveron Inc(NASDAQ: LGVN) a patent related to ...
12 Aug, 2022
12:20
FinancialContent
Longeveron (NASDAQ:LGVN) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors ...
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per ...
11 Aug, 2022
14:03
FinancialContent
Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors ...
09 Aug, 2022
According toGrand View Research, the global cell therapy market was valued at $7.8 billion in 2020 and is expected to expand at a ...
02 Aug, 2022
Recent publishing of Longeveron Inc.’s (NASDAQ: LGVN) peer-reviewed study in the Journal of the Alzheimer’s Association is a ...
28 Jul, 2022
The U.S. Department of Veterans Affairs (VA) partnered with Longeveron Inc. (NASDAQ: LGVN) to explore the clinical-stage biotech’s ...
08 Jul, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. The post 7 Moonshot Investments Upending a $10 Trillion Industry appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the ...
07 Jul, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday ...
U.S. stocks traded higher this morning, following the release of data on initial jobless claims. The Dow traded up 0.58% to 31,218.76 ...
25 Jun, 2022
24 Jun, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next. The post 7 Ways to Prepare for a Recession: An Investor’s Guide appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
15 Jun, 2022
Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are ...
16 May, 2022
20:57
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward. The post How to Buy Stocks in a Recession appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
13 May, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Switzerland ...
12:13
FinancialContent
Longeveron (NASDAQ:LGVN) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors ...
09:05
FinancialContent
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at ...
12 May, 2022
14:25
FinancialContent
Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it's for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
10 May, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Pfizer ...
09 May, 2022
06 May, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments. The post Follow the Insiders and Buy the Dip in These 3 Stocks appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
27 Apr, 2022
08:27
FinancialContent
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product ...
21 Apr, 2022
08:52
FinancialContent
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded ...
19 Apr, 2022
Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has risen 35.04% since its last report. The company recently ...
18 Apr, 2022
Photo by Caleb Fisher on Unsplash This post contains sponsored advertising content. This content is for informational purposes only ...
13 Apr, 2022
Longeveron Inc(NASDAQ: LGVN) has announced a Cooperative Research and Development Agreement (CRADA) with the United States ...
11 Apr, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur ...
08 Apr, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. The post Recession Fears are Creating a Golden Opportunity for Biotech Stocks appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Related Articles